Biotech7 months ago
AstraZeneca Aims to Double its Turnover Until 2030, up to 73.7 Billion Euros
AstraZeneca aims to nearly double its 2023 sales to $80 billion by 2030, focusing on cancer and rare disease treatments. CEO Pascal Soriot highlighted twelve potential...